만성질환 관리 시장 : 질병 유형, 제품 유형, 최종사용자, 치료 유형, 전달 방식별 - 세계 예측(2025-2030년)

The Chronic Disease Management Market was valued at USD 9.33 billion in 2023, expected to reach USD 10.12 billion in 2024, and is projected to grow at a CAGR of 7.10%, to USD 15.09 billion by 2030.

Chronic Disease Management (CDM) involves comprehensive, continuous care and strategies designed to manage and improve patients' well-being suffering from long-lasting, non-communicable ailments such as diabetes, cardiovascular disease, and asthma. The necessity of CDM arises from the growing global prevalence of chronic diseases fueled by aging populations, sedentary lifestyles, and unhealthy diets. Its applications span telehealth services, patient education, lifestyle coaching, and medication management to ensure effective treatment adherence, reduce hospitalizations, and improve life quality. End-use sectors primarily include hospitals, clinics, patient-centric organizations, and home healthcare, increasingly adopting CDM solutions to enhance care efficiency.

Key factors influencing this market's growth include technological advancements in health monitoring devices, the rising adoption of telemedicine, and the integration of Artificial Intelligence (AI) for predictive analytics in patient treatment plans. Latest opportunities present in wearable technology and mobile health apps, which offer remote monitoring and data analytics, significantly improve patient engagement and adherence to prescribed therapies. Businesses should leverage these opportunities by fostering innovations in patient-centric platforms that integrate AI and IoT for real-time health tracking and personalized care.

However, challenges persist in data privacy concerns, limited interoperability between healthcare IT systems, and a lack of skilled professionals adept in emerging health technologies. Economic disparities impact access to CDM solutions, particularly in low-income regions, hindering market penetration. Companies must focus on building secure, interoperable systems that prioritize patient data security while advocating for policies that expand access to underserved markets.

To spur growth and innovation, businesses can explore avenues in AI-driven predictive analytics, blockchain for secure data sharing, and the development of low-cost, scalable digital health platforms. The CDM market represents a dynamic, growth-oriented landscape pivoting towards value-based care models, aiming to enhance the overall efficiency and efficacy of chronic disease management.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Disease Management Market

The Chronic Disease Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
  • Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
  • Growing awareness among healthcare providers and patients about the importance of chronic disease management
  • Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
• Market Restraints
  • High cost associated with advanced treatments, technologies, and long-term care
  • Concerns over data breaches, unauthorized access, and loss of sensitive patient information
• Market Opportunities
  • Expansion of mobile health platforms addressing chronic disease management in underserved communities
  • Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
  • Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
• Market Challenges
  • Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
  • Difficulties in ensuring patients adherence to their prescribed treatment plans

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Disease Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Disease Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Disease Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Disease Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Disease Management Market

A detailed market share analysis in the Chronic Disease Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Disease Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Disease Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Disease Management Market

A strategic analysis of the Chronic Disease Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Disease Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, Glooko, Inc., Health Catalyst Inc., Hinge Health, Inc., Lark Technologies, Inc., Livongo Health, Inc., Medtronic plc, Merck & Co., Inc., MySugr GmbH, Novo Nordisk A/S, Omada Health, Inc., Propeller Health, Roche Holding AG, Sanofi S.A., Virta Health Corp., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Chronic Disease Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Type, market is studied across Cancer, Cardiovascular Diseases, Chronic Kidney Diseases, Chronic Respiratory Diseases, and Diabetes.
• Based on Product Type, market is studied across Devices, Drugs, and Services. The Devices is further studied across Diagnostic Devices, Monitoring Devices, and Therapeutic Devices. The Drugs is further studied across Analgesics, Antihypertensive, Bronchodilators, and Insulin. The Services is further studied across Home Healthcare and Telemedicine.
• Based on End User, market is studied across Clinics, Homecare Settings, Hospitals, and Long-term Care Centers.
• Based on Care Type, market is studied across Professional Care and Self-care.
• Based on Delivery Mode, market is studied across Cloud-based and On-premise.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
    • 5.1.1.2. Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
    • 5.1.1.3. Growing awareness among healthcare providers and patients about the importance of chronic disease management
    • 5.1.1.4. Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with advanced treatments, technologies, and long-term care
    • 5.1.2.2. Concerns over data breaches, unauthorized access, and loss of sensitive patient information
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of mobile health platforms addressing chronic disease management in underserved communities
    • 5.1.3.2. Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
    • 5.1.3.3. Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
    • 5.1.4.2. Difficulties in ensuring patients adherence to their prescribed treatment plans
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Chronic Disease Management Market, by Disease Type

• 6.1. Introduction
• 6.2. Cancer
• 6.3. Cardiovascular Diseases
• 6.4. Chronic Kidney Diseases
• 6.5. Chronic Respiratory Diseases
• 6.6. Diabetes

7. Chronic Disease Management Market, by Product Type

• 7.1. Introduction
• 7.2. Devices
  • 7.2.1. Diagnostic Devices
  • 7.2.2. Monitoring Devices
  • 7.2.3. Therapeutic Devices
• 7.3. Drugs
  • 7.3.1. Analgesics
  • 7.3.2. Antihypertensive
  • 7.3.3. Bronchodilators
  • 7.3.4. Insulin
• 7.4. Services
  • 7.4.1. Home Healthcare
  • 7.4.2. Telemedicine

8. Chronic Disease Management Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Homecare Settings
• 8.4. Hospitals
• 8.5. Long-term Care Centers

9. Chronic Disease Management Market, by Care Type

• 9.1. Introduction
• 9.2. Professional Care
• 9.3. Self-care

10. Chronic Disease Management Market, by Delivery Mode

• 10.1. Introduction
• 10.2. Cloud-based
• 10.3. On-premise

11. Americas Chronic Disease Management Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Chronic Disease Management Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Chronic Disease Management Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca plc
• 3. Boehringer Ingelheim GmbH
• 4. DexCom, Inc.
• 5. Eli Lilly and Company
• 6. Glooko, Inc.
• 7. Health Catalyst Inc.
• 8. Hinge Health, Inc.
• 9. Lark Technologies, Inc.
• 10. Livongo Health, Inc.
• 11. Medtronic plc
• 12. Merck & Co., Inc.
• 13. MySugr GmbH
• 14. Novo Nordisk A/S
• 15. Omada Health, Inc.
• 16. Propeller Health
• 17. Roche Holding AG
• 18. Sanofi S.A.
• 19. Virta Health Corp.
• 20. Welldoc, Inc.